Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.21
+0.06 (0.54%)
At close: Mar 20, 2026, 4:00 PM EDT
11.43
+0.22 (1.96%)
After-hours: Mar 20, 2026, 7:42 PM EDT
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$471,995
Profits / Employee
-$596,353
Market Cap
883.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,300 |
| Valneva SE | 700 |
| UroGen Pharma | 291 |
| KalVista Pharmaceuticals | 270 |
| Xencor | 260 |
| Inhibrx Biosciences | 161 |
| Janux Therapeutics | 109 |
| GH Research | 73 |
PHAT News
- 10 days ago - Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript - Seeking Alpha
- 23 days ago - Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 26 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026 - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire